Clinical Trials in New York

Showing 11601-11620 of 19,464 trials

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

NCT01993186

The primary objectives of the study are to evaluate the efficacy of UX007 compared to placebo as measured by the reduction from randomization to Week 8 in frequency of seizures and to evaluate the safety of UX007 via adverse event (AE) rates, laboratory values, and electrocardiogram (ECG).

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Ultragenyx Pharmaceutical Inc36 participantsStarted Feb 2014

Aurora, Colorado, United States • Miami, Florida, United States • Orlando, Florida, United States +11 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease

NCT00866359

The purpose of this study is to assess whether Apremilast is safe and effective in the treatment of patients with Behcet Disease.

Behcet Syndrome

Amgen111 participantsStarted Aug 2009

Jacksonville, Florida, United States • Boston, Massachusetts, United States • New York, New York, United States +4 more locations

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease

Find Trials by Condition in New York

Treatment of Children With ADHD Who do Not Fully Respond to Stimulants

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care

Self-Management App for Patients With Left-Ventricular Assist Devices

A Gene Therapy Study for Hemophilia B

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease